Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pseudomonas aeruginosa.

C W Stratton

    Infection Control : IC
    |January 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Pseudomonas aeruginosa (P. aeruginosa) is a common pathogen causing infections due to its antimicrobial resistance. Effective treatment involves specific antibiotic combinations, while strain typing is reserved for epidemiological investigations.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Spontaneous cryptococcal peritoneal effusion: an unusual cytological diagnosis with a poor prognosis.

    Cytopathology : official journal of the British Society for Clinical Cytology·2016
    Same author

    The usefulness of the serum bactericidal test in orthopedic infections.

    Orthopedics·2014
    Same author

    Antimicrobial treatment of multiple sclerosis.

    Infection·2007
    Same author

    Introduction: PROTEKT against respiratory tract infection.

    Journal of chemotherapy (Florence, Italy)·2002
    Same author

    Chlamydia pneumoniae and chronic skin wounds: a focused review.

    The journal of investigative dermatology. Symposium proceedings·2002
    Same author

    Get a handle on resistance before it gets a handle on you: the PROTEKT US Surveillance Study. Prospective Resistant Organism Tracking and Epidemiology for Ketolide Telithromycin.

    Southern medical journal·2001
    Same journal

    Nosocomial infection rates at an oncology center.

    Infection control : IC·1988
    Same journal

    Linking hospital epidemiology and quality assurance: seasoned concepts in a new role.

    Infection control : IC·1988
    Same journal

    Housekeeping products: the choice is yours.

    Infection control : IC·1988
    Same journal

    Effect of preoperative shampoos with chlorhexidine or iodophor on emergence of resident scalp flora in neurosurgery.

    Infection control : IC·1988
    Same journal

    The use of intraperitoneal antibiotics to treat dialysis-associated peritonitis.

    Infection control : IC·1988
    Same journal

    A causal link between handwashing and risk of infection? Examination of the evidence.

    Infection control : IC·1988
    See all related articles

    Area of Science:

    • Microbiology
    • Infectious Diseases
    • Clinical Science

    Background:

    • Pseudomonas aeruginosa (P. aeruginosa) is ubiquitous in natural and hospital settings, often colonizing moist environments.
    • This opportunistic pathogen possesses inherent antimicrobial resistance and enzymatic capabilities, contributing to its significant role in primary and secondary infections.
    • While P. aeruginosa is readily cultured and identified in laboratories, determining its antimicrobial susceptibility presents challenges.

    Purpose of the Study:

    • To summarize the key characteristics of P. aeruginosa relevant to clinical practice.
    • To highlight challenges in susceptibility testing.
    • To provide guidance on current effective treatment strategies and strain typing applications.

    Main Methods:

    Related Experiment Videos

  • Literature review of P. aeruginosa epidemiology, pathogenicity, and laboratory characteristics.
  • Analysis of current antimicrobial susceptibility testing limitations.
  • Evaluation of recommended therapeutic regimens and diagnostic typing methods.

    • Main Results:

    • P. aeruginosa demonstrates widespread distribution and significant pathogenic potential.
    • Susceptibility testing for P. aeruginosa remains a clinical challenge.
    • Combined therapy with aminoglycosides and antipseudomonal beta-lactams is currently recommended.
    • Strain differentiation is valuable for specific epidemiological investigations.

    Conclusions:

    • P. aeruginosa infections require careful management due to resistance.
    • Optimal treatment relies on appropriate antimicrobial selection.
    • Strain typing should be judiciously applied for targeted epidemiological studies.